Yes, continue Tamiflu to complete the full 5-day course after discharge
This 64-year-old hospitalized patient should complete the standard 5-day course of oseltamivir (10 total doses), continuing treatment after discharge for the remaining 2 days. The IDSA guidelines explicitly recommend treating uncomplicated influenza for 5 days with oral oseltamivir 1, and the FDA labeling confirms this standard duration 2.
Rationale for Completing the Course
The evidence strongly supports completing the full treatment duration:
Standard treatment duration is 5 days (10 doses): The IDSA guidelines state clinicians should treat uncomplicated influenza for 5 days with oral oseltamivir 1. This patient is on day 3, meaning 2 days remain.
Hospitalized patients warrant full treatment: Since this patient required hospitalization, he meets criteria for antiviral treatment regardless of illness duration 1. The guidelines recommend treating "persons of any age who are hospitalized with influenza, regardless of illness duration prior to hospitalization" 1.
Premature discontinuation risks suboptimal outcomes: Shorter durations than the approved 5-day course may not be effective and could contribute to viral resistance emergence 3. The FDA labeling instructs patients to "complete the entire treatment of 10 doses (capsules or suspension), even if you feel better" 2.
When to Consider Extended Duration
While standard 5-day treatment applies to this patient, be aware that longer treatment courses may be considered for:
- Immunocompromised patients with protracted viral replication 1
- Severe lower respiratory tract disease (pneumonia, ARDS) requiring hospitalization 1
- Critically ill ICU patients, where recent evidence suggests prolonged oseltamivir (beyond 5 days) reduced ICU mortality compared to standard 5-day courses 4
However, this patient appears to be improving sufficiently for discharge, suggesting uncomplicated disease that warrants standard 5-day treatment only.
Practical Discharge Instructions
Provide clear instructions to complete days 4 and 5:
- Continue 75 mg twice daily (morning and evening) for 2 more days
- Take with food to reduce gastrointestinal side effects 2
- Complete all doses even if symptoms have resolved 2
Common Pitfalls to Avoid
- Don't stop early based on clinical improvement: Patients often feel better before completing treatment, but stopping prematurely may allow viral replication to continue
- Don't confuse treatment duration with prophylaxis duration: Prophylaxis uses different dosing (once daily) and duration (7-10 days for household exposure, up to 6 weeks for community outbreak) 2
- Monitor for bacterial superinfection: If the patient deteriorates after initial improvement, investigate bacterial coinfection 1